133 related articles for article (PubMed ID: 21315192)
1. A founder effect at the EPCAM locus in Congenital Tufting Enteropathy in the Arabic Gulf.
Salomon J; Espinosa-Parrilla Y; Goulet O; Al-Qabandi W; Guigue P; Canioni D; Bruneau J; Alzahrani F; Almuhsen S; Cerf-Bensussan N; Jeanpierre M; Brousse N; Lyonnet S; Munnich A; Smahi A
Eur J Med Genet; 2011; 54(3):319-22. PubMed ID: 21315192
[TBL] [Abstract][Full Text] [Related]
2. Identification of EpCAM as the gene for congenital tufting enteropathy.
Sivagnanam M; Mueller JL; Lee H; Chen Z; Nelson SF; Turner D; Zlotkin SH; Pencharz PB; Ngan BY; Libiger O; Schork NJ; Lavine JE; Taylor S; Newbury RO; Kolodner RD; Hoffman HM
Gastroenterology; 2008 Aug; 135(2):429-37. PubMed ID: 18572020
[TBL] [Abstract][Full Text] [Related]
3. Outcome associated with EPCAM founder mutation c.499dup in Qatar.
Hassan K; Sher G; Hamid E; Hazima KA; Abdelrahman H; Al Mudahka F; Al-Masri W; Sankar J; Daryaee M; Shawish R; Khan MA; Nawaz Z
Eur J Med Genet; 2020 Oct; 63(10):104023. PubMed ID: 32735948
[TBL] [Abstract][Full Text] [Related]
4. A novel nonsense mutation in the EpCAM gene in a patient with congenital tufting enteropathy.
Thoeni C; Amir A; Guo C; Zhang S; Avitzur Y; Heng YM; Cutz E; Muise AM
J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):18-21. PubMed ID: 24048167
[TBL] [Abstract][Full Text] [Related]
5. Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.
Salomon J; Goulet O; Canioni D; Brousse N; Lemale J; Tounian P; Coulomb A; Marinier E; Hugot JP; Ruemmele F; Dufier JL; Roche O; Bodemer C; Colomb V; Talbotec C; Lacaille F; Campeotto F; Cerf-Bensussan N; Janecke AR; Mueller T; Koletzko S; Bonnefont JP; Lyonnet S; Munnich A; Poirier F; Smahi A
Hum Genet; 2014 Mar; 133(3):299-310. PubMed ID: 24142340
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of EpCam mutation in mice and men.
Mueller JL; McGeough MD; Peña CA; Sivagnanam M
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G278-88. PubMed ID: 24337010
[TBL] [Abstract][Full Text] [Related]
7. Absence of cell-surface EpCAM in congenital tufting enteropathy.
Schnell U; Kuipers J; Mueller JL; Veenstra-Algra A; Sivagnanam M; Giepmans BN
Hum Mol Genet; 2013 Jul; 22(13):2566-71. PubMed ID: 23462293
[TBL] [Abstract][Full Text] [Related]
8. mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.
Guerra E; Lattanzio R; La Sorda R; Dini F; Tiboni GM; Piantelli M; Alberti S
PLoS One; 2012; 7(11):e49302. PubMed ID: 23209569
[TBL] [Abstract][Full Text] [Related]
9. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
[TBL] [Abstract][Full Text] [Related]
10. Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction.
Kozan PA; McGeough MD; Peña CA; Mueller JL; Barrett KE; Marchelletta RR; Sivagnanam M
J Mol Med (Berl); 2015 May; 93(5):535-45. PubMed ID: 25482158
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of Italian patients with congenital tufting enteropathy.
d'Apolito M; Pisanelli D; Faletra F; Giardino I; Gigante M; Pettoello-Mantovani M; Goulet O; Gasparini P; Campanozzi A
World J Pediatr; 2016 May; 12(2):219-24. PubMed ID: 26684320
[TBL] [Abstract][Full Text] [Related]
12. Identification of a founder EPCAM deletion in Spanish Lynch syndrome families.
Mur P; Pineda M; Romero A; Del Valle J; Borràs E; Canal A; Navarro M; Brunet J; Rueda D; Ramón Y Cajal T; Lázaro C; Caldés T; Blanco I; Soto JL; Capellá G
Clin Genet; 2014 Mar; 85(3):260-6. PubMed ID: 23530899
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of intestinal biopsies for pediatric enteropathy: a proposed immunohistochemical panel approach.
Martin BA; Kerner JA; Hazard FK; Longacre TA
Am J Surg Pathol; 2014 Oct; 38(10):1387-95. PubMed ID: 25188866
[TBL] [Abstract][Full Text] [Related]
14. Tufting enteropathy and chronic arthritis: a newly recognized association with a novel EpCAM gene mutation.
Al-Mayouf SM; Alswaied N; Alkuraya FS; Almehaidib A; Faqih M
J Pediatr Gastroenterol Nutr; 2009 Nov; 49(5):642-4. PubMed ID: 19820410
[No Abstract] [Full Text] [Related]
15. EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.
Pathak SJ; Mueller JL; Okamoto K; Das B; Hertecant J; Greenhalgh L; Cole T; Pinsk V; Yerushalmi B; Gurkan OE; Yourshaw M; Hernandez E; Oesterreicher S; Naik S; Sanderson IR; Axelsson I; Agardh D; Boland CR; Martin MG; Putnam CD; Sivagnanam M
Hum Mutat; 2019 Feb; 40(2):142-161. PubMed ID: 30461124
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for EpCAM as the gene for congenital tufting enteropathy.
Sivagnanam M; Schaible T; Szigeti R; Byrd RH; Finegold MJ; Ranganathan S; Gopalakrishna GS; Tatevian N; Kellermayer R
Am J Med Genet A; 2010 Jan; 152A(1):222-4. PubMed ID: 20034091
[No Abstract] [Full Text] [Related]
17. Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients.
Alavi A; Elahi E; Tehrani MH; Amoli FA; Javadi MA; Rafati N; Chiani M; Banihosseini SS; Bayat B; Kalhor R; Amini SS
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4490-7. PubMed ID: 17898270
[TBL] [Abstract][Full Text] [Related]
18. Enteroids expressing a disease-associated mutant of EpCAM are a model for congenital tufting enteropathy.
Das B; Okamoto K; Rabalais J; Kozan PA; Marchelletta RR; McGeough MD; Durali N; Go M; Barrett KE; Das S; Sivagnanam M
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G580-G591. PubMed ID: 31433211
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification.
Musulen E; Blanco I; Carrato C; Fernandez-Figueras MT; Pineda M; Capella G; Ariza A
Hum Pathol; 2013 Mar; 44(3):412-6. PubMed ID: 23026194
[TBL] [Abstract][Full Text] [Related]
20. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.
Kovacs ME; Papp J; Szentirmay Z; Otto S; Olah E
Hum Mutat; 2009 Feb; 30(2):197-203. PubMed ID: 19177550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
